Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D'Incalci

Showing results (41-50 of 339) with videos related to

Pageof 34
Sort By:
Cytometry|January 1, 1990
Synchronisation of cancer cell lines of human origin using methotrexateS Sen, E Erba, M D'Incalci
Pharmacology & Therapeutics|January 1, 1988
Effects of cancer disease on the metabolism of anticancer agentsS Garattini, P Ghezzi, M D'Incalci
Cancer Treatment Reports|February 1, 1984
Pharmacokinetic studies of anticancer drugs in tumor-bearing animalsM G Donelli, M D'Incalci, S Garattini
British Journal of Cancer|April 1, 1996
Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemiaT Colombo, O Gonzalez Paz, M D'Incalci
Cancer Chemotherapy and Pharmacology|January 1, 1992
Do anticancer agents reach the tumor target in the human brain?M G Donelli, M Zucchetti, M D'Incalci
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Not only tumor but also therapy heterogeneityS Garattini, I Fuso Nerini, M D'Incalci
Biochemical Pharmacology|February 9, 1993
The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agentsH M Coley, N Mongelli, M D'Incalci
Nucleic Acids Research|November 1, 1996
Characterization of a protein recognizing minor groove binders-damaged DNAG Colella, M Bonfanti, M D'Incalci, et al.
Anticancer Research|May 1, 1997
Effect of G:C-->A:T transition, potentially arising from O6-guanine alkylation, in the transcription regulation of c-fos serum response elementM Bonfanti, G Colella, M Broggini, et al.
Expert Opinion on Investigational Drugs|January 5, 2002
Development of distamycin-related DNA binding anticancer drugsS Marchini, M Broggini, C Sessa, et al.
Pageof 34

Showing results (41-50 of 339) with videos related to

Sort By:
Pageof 34
Cytometry|January 1, 1990
Synchronisation of cancer cell lines of human origin using methotrexateS Sen, E Erba, M D'Incalci
Pharmacology & Therapeutics|January 1, 1988
Effects of cancer disease on the metabolism of anticancer agentsS Garattini, P Ghezzi, M D'Incalci
Cancer Treatment Reports|February 1, 1984
Pharmacokinetic studies of anticancer drugs in tumor-bearing animalsM G Donelli, M D'Incalci, S Garattini
British Journal of Cancer|April 1, 1996
Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemiaT Colombo, O Gonzalez Paz, M D'Incalci
Cancer Chemotherapy and Pharmacology|January 1, 1992
Do anticancer agents reach the tumor target in the human brain?M G Donelli, M Zucchetti, M D'Incalci
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Not only tumor but also therapy heterogeneityS Garattini, I Fuso Nerini, M D'Incalci
Biochemical Pharmacology|February 9, 1993
The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agentsH M Coley, N Mongelli, M D'Incalci
Nucleic Acids Research|November 1, 1996
Characterization of a protein recognizing minor groove binders-damaged DNAG Colella, M Bonfanti, M D'Incalci, et al.
Anticancer Research|May 1, 1997
Effect of G:C-->A:T transition, potentially arising from O6-guanine alkylation, in the transcription regulation of c-fos serum response elementM Bonfanti, G Colella, M Broggini, et al.
Expert Opinion on Investigational Drugs|January 5, 2002
Development of distamycin-related DNA binding anticancer drugsS Marchini, M Broggini, C Sessa, et al.
Pageof 34